The Napkin in the Water
In the basement of a dairy plant in St. Paul, Minnesota, sometime in the early 1920s, a salesman named Merritt J. Osborn watched a worker scrub a milk bottle by hand. The bottle wasn't getting clean — not really. A thin film clung to the glass, invisible to the naked eye but teeming with bacteria that would spoil the milk within hours. Osborn had a product, a powdered compound called "Soilax" he'd been peddling door-to-door for household use, and he had what turned out to be a century-defining insight: the real market for clean wasn't consumers. It was the hidden, unglamorous, absolutely non-negotiable infrastructure of industrial hygiene — the invisible layer between civilization and contamination. A hundred years later, that insight generates $16 billion in annual revenue.
Ecolab is one of the most consequential companies most people have never thought about. Its chemicals, equipment, digital monitoring systems, and — critically — its army of 25,000 field service representatives touch nearly every surface where human beings eat, drink, sleep, receive medical care, or manufacture the products that sustain modern life. Three million customer locations in over 170 countries. Forty-four percent of the world's processed food passes through Ecolab-treated facilities. Every major hotel chain. Every major quick-service restaurant. The operating rooms. The semiconductor fabs. The offshore oil rigs. The cruise ships. The breweries. If you've eaten at a restaurant, slept in a hotel, or had surgery in a hospital in the developed world in the past decade, Ecolab's chemistry was almost certainly on the surfaces around you.
What makes the company genuinely strange — and strategically fascinating — is the gap between its ubiquity and its anonymity. Ecolab operates in a category so fundamental it barely registers as a category at all: cleaning. Water treatment. Pest elimination. The prevention of things going wrong. This is not a business that inspires magazine covers or CNBC segments. There is no Ecolab keynote. No cult of personality. No consumer brand recognition whatsoever. And yet the company has compounded earnings at roughly 12–14% annually for decades, sports gross margins above 40%, and commands a market capitalization north of $70 billion — larger than many of the household names whose facilities it cleans.
The paradox at the heart of Ecolab is that its competitive advantage is built from the least glamorous materials imaginable — soap, water, data about soap and water — assembled into a business model so deeply embedded in its customers' operations that switching costs approach infinity. It is the quiet monopoly of the mundane.
By the Numbers
Ecolab at a Glance
$16.1B2024 revenue
~48,000Employees worldwide
3M+Customer locations served
170+Countries of operation
~$70BMarket capitalization
~25,000Field service representatives
44%Of world's processed food touches Ecolab systems
38 yrsConsecutive dividend increases
A Salesman's Religion
Merritt Osborn was not a chemist. He was a salesman — a critical distinction in Ecolab's DNA that persists a full century later. Born in 1884 in rural Minnesota, Osborn had tried his hand at several ventures before stumbling onto Economics Laboratory, the company he incorporated in 1923 with a single product and an idea about distribution. Soilax worked well enough as a household cleaner, but Osborn realized that selling to homemakers meant competing on price in an undifferentiated market. Selling to dairies, restaurants, and hotels meant competing on outcomes — and outcomes could be measured, demonstrated, and, crucially, charged for at a premium.
The founding model was deceptively simple: don't just sell the chemical; sell the result. Osborn dispatched salesmen not to take orders but to enter the customer's facility, observe the cleaning process, identify failures, and demonstrate — on site, in real time — that Economics Laboratory's product delivered a measurably cleaner outcome. The salesman was part chemist, part consultant, part quality inspector. The product was never really the powder in the drum. The product was the relationship, the expertise, the assurance that someone who understood your operation was watching the variables you couldn't see.
This model — chemicals plus service plus measurement — became the triple helix of Ecolab's business. It has been elaborated, digitized, and extended across dozens of industries over the ensuing century, but its essential architecture hasn't changed. The company still sends human beings into customer facilities to observe, optimize, and ensure outcomes. It still bundles chemistry with expertise. And it still prices on value delivered rather than volume consumed.
We don't sell soap. We sell clean.
The early decades were steady but unremarkable. Economics Laboratory expanded its institutional cleaning products through the 1930s and '40s, adding dishwashing compounds for restaurants and sanitizers for food processing. The company went public in 1957. Revenue was modest — a few million dollars — but the pattern was established: find an industry where cleanliness is operationally critical, develop chemistry tailored to that industry's specific soils and surfaces, then embed your people inside the customer's operation until they become indistinguishable from the customer's own staff.
The Schuman Doctrine
If Osborn established the religion, E.B. Osborn (Merritt's son) maintained the parish, and Fred Lanners expanded the geography, it was the arrival of Pierson M. "Sandy" Grieve and then the long reign of the Schuman family that transformed Economics Laboratory from a Midwestern specialty chemical company into a global operating system for institutional cleanliness.
But the intellectual architect of modern Ecolab was arguably not a single leader but a principle that crystallized across multiple administrations: the relentless acquisition and integration of adjacent service categories, always filtered through the same delivery model. Don't just clean the dishes — eliminate the pests. Don't just treat the water — monitor the entire water system. Don't just sanitize the operating room — manage infection prevention across the hospital. Each adjacency deepened the customer relationship, raised switching costs, and created cross-selling opportunities that no specialist competitor could match.
The company renamed itself Ecolab in 1986 — a move that signaled both the broadening beyond its laboratory roots and a growing environmental consciousness in its customer base. By this point, the company had assembled a portfolio spanning institutional cleaning (restaurants, hotels, healthcare), food and beverage processing sanitation, water treatment, and pest elimination. Each segment operated with its own specialized chemistry and field service teams, but all shared the same go-to-market architecture: direct sales force, on-site service, value-based pricing, long-term contracts.
Key acquisitions and milestones in the company's first eight decades
1923Merritt J. Osborn incorporates Economics Laboratory in St. Paul, MN.
1957Economics Laboratory goes public on the NYSE.
1961Enters the pest elimination business, adding a critical adjacency.
1986Renames to Ecolab Inc., reflecting its expanded portfolio.
1991Acquires ChemLawn (later divested); begins international push.
2001Acquires Henkel's institutional cleaning business in a $3B deal, dramatically expanding European presence.
2011Merges with Nalco in a transformative $5.4B deal, entering industrial water treatment at scale.
The Nalco Bet
The story of modern Ecolab cannot be told without lingering on a single deal: the 2011 merger with Nalco Holding Company, a $5.4 billion transaction that was, by a wide margin, the largest in the company's history. It was orchestrated by Douglas M. Baker Jr., who had become CEO in 2004 and would go on to lead Ecolab for nearly two decades — a tenure that reshaped the company more profoundly than any since the founding.
Baker is a paradox of corporate leadership: an intensely competitive operator with an almost Calvinist devotion to process, discipline, and incremental improvement, leading a company that makes its money from the unseen. Raised in Missouri, educated at the College of the Holy Cross and then Stanford's MBA program, Baker joined Ecolab in 1989 and rose through the sales organization — the same direct-service crucible that had shaped every Ecolab leader before him. He understood, viscerally, that Ecolab's moat was not its chemistry (competitors could formulate similar compounds) but its installed base of relationships — the 25,000 service reps visiting customer sites, the data they collected, the trust they accumulated.
Nalco was a bet on water. Specifically, it was a bet that water — its treatment, recycling, conservation, and optimization in industrial processes — was going to become the defining resource constraint of the 21st century, and that the company that could manage industrial water most intelligently would occupy an unassailable strategic position. Nalco brought $4.4 billion in revenue, deep expertise in boiler water treatment, cooling water management, and process water optimization, and — critically — a customer base that overlapped only partially with Ecolab's existing institutional clients. Ecolab was strong in hospitality, food service, and healthcare. Nalco was strong in heavy industry, manufacturing, power generation, and oil refining.
Water is to this century what energy was to the last. The companies that help their customers use less of it, more intelligently, will define the next era of industrial productivity.
The strategic logic was elegant: combine Ecolab's institutional cleaning and food safety platform with Nalco's industrial water treatment capabilities, creating a company that could manage both the chemistry and the water in virtually any facility on earth. Clean surfaces. Clean water. Monitored by the same digital infrastructure. Sold by the same relationship-driven model. The combined entity would be too broad for any specialist to challenge and too embedded for any generalist to displace.
The market was skeptical. Ecolab's stock dropped 7% on the announcement. Analysts worried about integration risk, the cyclicality of Nalco's energy-sector exposure, and whether the cultural DNA of a hospitality-focused sales organization could absorb a heavy-industry water treatment business. Baker spent the next three years proving the skeptics wrong — not through dramatic transformation but through the patient, almost boring work of cross-training sales teams, harmonizing IT systems, and demonstrating to existing Ecolab customers that the same company that sanitized their kitchens could now optimize their cooling towers.
The deal worked. By 2015, the combined company had achieved $250 million in cost synergies — exceeding the original target — and cross-selling between legacy Ecolab and legacy Nalco customers was generating incremental revenue that neither company could have captured alone. The Nalco acquisition didn't just add a revenue line; it fundamentally expanded Ecolab's addressable market from roughly $45 billion to over $150 billion, redefining the company from "institutional cleaning" to "water, hygiene, and infection prevention."
The Invisible Service Economy
To understand why Ecolab's competitive position is so durable, you have to understand the peculiar economics of what it actually sells. Ecolab is often categorized as a "specialty chemicals" company, and this is technically correct but strategically misleading. Chemicals — soaps, sanitizers, scale inhibitors, biocides, corrosion inhibitors — are the physical substrate of the business. But the value proposition is not the chemical. It is the outcome the chemical enables, delivered through a service model that makes the chemical almost incidental.
Consider a typical Ecolab customer: a mid-size hotel chain with 200 properties. Each property has a commercial kitchen, a laundry facility, guest bathrooms, a swimming pool, and HVAC systems with cooling towers. Each of these environments has distinct chemistry needs — different soils, different surfaces, different water conditions, different regulatory requirements. Ecolab doesn't just ship drums of detergent to this customer. It installs proprietary dispensing equipment in every kitchen, laundry, and housekeeping closet. It connects those dispensers to its ECOLAB3D digital platform, which monitors chemical usage in real time, flags anomalies, and generates compliance reports. It assigns dedicated field service representatives who visit each property on a regular cadence — often weekly — to inspect equipment, test water chemistry, train staff, and optimize chemical concentrations.
The hotel doesn't think of Ecolab as a chemical supplier. It thinks of Ecolab as the company that ensures its kitchens pass health inspections, its laundry comes out spotless, its pools are safe, and its cooling towers don't breed Legionella. The chemical is a delivery mechanism for a compliance guarantee, an operating assurance, a bundle of risk mitigation that the hotel cannot replicate internally without hiring dozens of specialized technicians it doesn't want to employ.
This model creates switching costs that are almost comically high relative to the dollar value of the chemicals themselves. To replace Ecolab, the hotel would need to rip out every dispenser, disconnect the monitoring system, find alternative suppliers for five different chemical categories, hire its own field technicians, build its own compliance reporting, and — most critically — accept the risk of a health inspection failure, a Legionella outbreak, or a food safety incident during the transition. The cost of Ecolab's services might represent 1–3% of the hotel's operating budget. The cost of getting it wrong is existential.
This asymmetry — low cost to the customer, catastrophic downside of failure — is the atomic structure of Ecolab's moat. The company operates in the space where the economic value of its service is a fraction of the economic cost of the problem it prevents. No rational CFO switches cleaning providers to save $50,000 a year when a single foodborne illness outbreak could cost $5 million in lawsuits, lost revenue, and brand damage.
The Field Force as Flywheel
The most distinctive asset Ecolab possesses — and the one most difficult for competitors to replicate — is not a patent portfolio, a manufacturing network, or a software platform. It is 25,000 human beings who walk into customer facilities every day.
Ecolab's field service force is the largest dedicated institutional hygiene sales and service organization on earth. These are not traditional salespeople in the sense that they spend their days generating leads and closing contracts. They are, more accurately, technical consultants embedded inside customer operations on an ongoing basis. They test water samples. They calibrate dispensers. They train kitchen staff on proper sanitization protocols. They identify pest entry points. They conduct energy and water audits. They generate data.
That last function — data generation — is where the flywheel accelerates. Every service visit produces structured operational data: water quality readings, chemical consumption rates, equipment performance metrics, compliance scores, incident logs. Aggregated across three million customer locations, this dataset is unparalleled. No other company on earth has a comparable real-time view of water chemistry, sanitation compliance, and resource consumption across the global hospitality, food processing, and industrial landscape.
This data feeds Ecolab's ECOLAB3D digital platform and its newer Ecolab One intelligence system, which use machine learning to identify optimization opportunities — reducing water consumption by 15% in a bottling plant, cutting chemical costs by 20% in a laundry operation, predicting equipment failures before they cause downtime. The digital tools make the field force more productive, enabling each rep to serve more locations and deliver more value per visit. And the more value the rep delivers, the deeper the customer relationship, the more data generated, the smarter the algorithms, the more valuable the next visit.
It is a flywheel, and it is spinning.
Our field service associates are inside three million customer locations. That is not a number you replicate. That is not a moat you build in five years. That is a hundred years of compounding trust.
The Beck Era: From Volume to Value
Douglas Baker stepped down as CEO in January 2021, handing the reins to Christophe Beck, a Belgian-born engineer who had run Ecolab's Nalco Water division and, before that, its European institutional business. Beck's promotion was a signal: the future of Ecolab was as much about water as about cleaning, and the company needed a leader who could speak the language of industrial process optimization as fluently as the language of hotel housekeeping.
Beck inherited a company navigating the aftermath of COVID-19 — a pandemic that had simultaneously devastated Ecolab's largest end market (hospitality, which fell off a cliff in 2020) and validated its core value proposition (the world suddenly cared, desperately, about sanitation). Revenue had dropped from $12.9 billion in 2019 to $11.8 billion in 2020 as hotels closed and restaurants shuttered. But the recovery, when it came, revealed something important: customers who had paused Ecolab services during lockdowns returned almost universally, often adding new service lines. The pandemic had not eroded Ecolab's relationships; it had reinforced them.
Beck's strategic vision — articulated in a framework the company calls "Ecolab One" — centers on a shift from selling chemical volume to selling measurable outcomes. The idea is not new (Osborn was essentially selling outcomes in 1923), but the digital infrastructure to execute it at scale is. ECOLAB3D and its successors aggregate real-time data from connected dispensing systems, water monitoring sensors, and field service reports to quantify, for each customer, exactly how much water, energy, and chemical they consumed and exactly how much they saved relative to baseline.
This shift matters economically. Volume-based pricing incentivizes the customer to use less product — a perverse dynamic that pits Ecolab's revenue growth against its customer's cost optimization. Value-based pricing aligns Ecolab's incentives with the customer's outcomes: if Ecolab helps you save $500,000 in water and energy costs, it captures a percentage of that savings. The customer's gain becomes Ecolab's gain. The math is elegant and the margin profile is superior — delivering value-based services requires expertise and data, not more drums of chemicals.
Under Beck, Ecolab has accelerated this transition, pushing organic revenue growth to 12% in 2022 and mid-single digits in 2023 and 2024, with operating margins expanding to approximately 16% adjusted — approaching the company's long-stated target of 20% by the end of the decade. The margin story is the quiet revolution: Ecolab has been a growth company masquerading as a margin expansion story, or perhaps the reverse.
Water, or the Scarcity Premium
If Ecolab's institutional cleaning business is the engine that generates cash flow, its water business — inherited from Nalco and expanded through subsequent acquisitions — is the asset that justifies the multiple. Water is the strategic thesis, the long-duration bet, the reason the company trades at 30x+ forward earnings despite being, at its core, a soap company.
The argument is straightforward, if uncomfortable. Global freshwater demand is projected to exceed supply by 40% by 2030, according to the UN. Industrial water consumption accounts for roughly 20% of global freshwater withdrawals — and that share is growing as manufacturing expands in water-stressed regions. Regulatory pressure on industrial water discharge is tightening in every major market. The cost of water itself is rising — municipal water rates in the U.S. have increased at roughly twice the rate of inflation for the past two decades.
Ecolab's water business — housed primarily in its Global Industrial segment — helps customers use less water, recycle more water, and treat wastewater to regulatory standards. The applications range from the mundane (optimizing cooling tower chemistry to reduce blowdown cycles) to the existential (enabling a semiconductor fab in Arizona to recycle 95% of its ultra-pure process water in a region where aquifer levels are dropping measurably each year).
The total addressable market for water treatment and management is estimated at $50–60 billion and growing at 6–8% annually. Ecolab holds perhaps 10–12% of this market, making it the largest player in a still-fragmented landscape. The opportunity is immense — and it is structural, not cyclical. Water scarcity doesn't reverse when interest rates change. The regulatory ratchet doesn't loosen. The physics of climate change doesn't negotiate.
What makes water particularly powerful for Ecolab's business model is that water management exhibits the same asymmetric risk profile as food safety. A cooling tower Legionella outbreak can kill people. A wastewater discharge violation can shut down a factory and generate eight-figure fines. A water shortage can halt semiconductor production — and in a world where a single advanced fab costs $20 billion, the $2 million annual water treatment contract isn't a cost center; it's an insurance policy on a capital asset.
The Pest in the Machine
Tucked within Ecolab's portfolio is a business that receives less attention than it deserves: pest elimination. Ecolab's pest business, rebranded as "Ecolab Pest Elimination" but tracing its lineage through the acquisition of various pest control operators over decades, generates approximately $1 billion in annual revenue and operates with margins that rival or exceed the company's overall average.
The pest business is strategic in ways that its modest revenue share might not suggest. First, it is the ultimate recurring revenue model — pests don't stop coming, and any gap in service is immediately visible (and viscerally unpleasant) to customers and their customers. Second, it deepens the relationship: the same sales team that manages a restaurant's dish machine and floor cleaner now also manages its rodent stations and fly lights, creating another thread of dependency. Third, it benefits from the same data infrastructure — pest activity patterns, seasonal trends, facility vulnerability assessments — that Ecolab feeds into its digital platform.
But the pest business also illustrates a tension in Ecolab's strategy. The largest pure-play competitor in pest control is Rentokil Initial, which completed its $6.7 billion acquisition of Terminix in 2022 to create a pest control behemoth with roughly $6 billion in pest-specific revenue. Against a focused competitor of that scale, Ecolab's $1 billion pest business is a complement to its broader offering, not a standalone champion. The question is whether bundling — the ability to offer pest, cleaning, water, and sanitation from a single provider — creates enough value to offset the scale advantages of a specialist.
So far, the answer appears to be yes in institutional and commercial settings (restaurants, hotels, food plants), where the operational simplicity of a single vendor outweighs any price advantage a specialist might offer. The answer is less clear in residential pest control, which Ecolab has largely avoided, or in industrial pest applications where Rentokil's specialized capabilities may be superior.
The Healthcare Gambit
Ecolab's healthcare business — approximately $2 billion in revenue, housed within the Global Healthcare & Life Sciences segment — represents both the company's highest-margin opportunity and its most strategically contested terrain. Healthcare-associated infections (HAIs) kill an estimated 99,000 Americans annually and cost the U.S. healthcare system $28–45 billion per year. The surfaces, instruments, and water systems in hospitals are, quite literally, matters of life and death. Ecolab's value proposition — clean surfaces, safe water, trained staff, documented compliance — fits healthcare like a glove fits a surgeon.
The company entered healthcare seriously through a series of acquisitions, including Microtek Medical (surgical products) and the gradual extension of its institutional cleaning platforms into hospital environments. Its products span instrument reprocessing (the sterilization of surgical tools between procedures), environmental hygiene (surface disinfection in patient rooms and operating suites), hand hygiene compliance monitoring, and water management for healthcare facilities.
But healthcare is not hospitality. The regulatory environment is more complex, the sales cycles longer, the buying structures more Byzantine (hospitals buy through group purchasing organizations, or GPOs, which negotiate on behalf of thousands of member facilities). The competitive set is different, too: Ecolab competes not just against other chemical companies (Diversey, now part of Solenis) but against specialized medical device and infection prevention companies like Steris (market cap ~$22 billion) and Cantel Medical (acquired by Steris in 2021 for $4.6 billion).
Healthcare is where Ecolab's cross-selling model faces its stiffest test. A hospital's infection preventionist cares deeply about surface disinfection efficacy data, instrument reprocessing validation, and compliance with Joint Commission standards. They care less about whether the same company also cleans the hospital's cafeteria kitchen, treats its cooling water, and manages its pest control. The bundling advantage that is overwhelming in a hotel may be merely incremental in a hospital.
Ecolab is betting that its digital compliance monitoring and data analytics — the ability to demonstrate, with real-time dashboards, that every surface in every room was disinfected according to protocol — will differentiate it in a market where proving compliance is becoming as important as achieving it. The bet is not yet fully proven, but the direction of regulatory travel (more documentation, more accountability, more liability for HAIs) favors the company with the most comprehensive data platform.
The Margin Staircase
For much of its history, Ecolab was a growth story with underwhelming margins. Through the 2000s and early 2010s, the company's operating margins hovered in the low-to-mid teens — respectable for a service-intensive chemical business, but well below what its switching costs and competitive position might suggest. The Nalco acquisition diluted margins further, as Nalco's commodity-chemical-adjacent water treatment business carried a lower margin profile than Ecolab's institutional segments.
Baker identified this gap and made margin expansion a central pillar of his strategic agenda. The playbook was methodical: raise prices annually (Ecolab's pricing power, like cockroaches, is remarkably resilient), drive procurement savings through scale, rationalize manufacturing and supply chain, and shift the revenue mix toward higher-margin service and digital offerings. Progress was steady but unspectacular — a testament to the difficulty of extracting margin improvement from a business where 25,000 field technicians drive to customer sites every day.
The real margin acceleration came during and after the COVID era. Raw material costs — which had spiked in 2021–2022 as chemical feedstocks surged — began to normalize in 2023. Ecolab, which had pushed through significant price increases during the inflationary period, retained much of the pricing while costs fell. The result was a dramatic gross margin expansion, from roughly 36% in 2021 to approximately 42% by late 2024.
Beck has articulated a target of 20% adjusted operating margins by the late 2020s — up from approximately 16% in 2024. If achieved, this would represent a fundamental re-rating of Ecolab's earnings power, transforming it from a mid-teens margin business generating perhaps $3 billion in operating income to a high-teens or 20% margin business generating $4 billion or more on current revenues.
The margin expansion thesis rests on three levers: continued pricing discipline, the shift to value-based (rather than volume-based) commercial models, and the productivity gains from digitizing the field force. Each lever is individually plausible. Together, they represent the most ambitious restructuring of Ecolab's economic model since the Nalco deal.
We are in the early innings of margin expansion. The digital transformation of our service model changes the fundamental economics of every customer interaction.
The Compounding Cathedral
There is a particular type of company that the stock market loves but struggles to categorize — a business that is simultaneously boring and irreplaceable, whose competitive advantages compound invisibly over decades, whose revenue growth looks modest in any single quarter but whose cumulative effect is staggering when measured over decades. Ecolab is the archetype.
Consider the arithmetic. Ecolab has increased its dividend for 38 consecutive years. It has compounded earnings per share at roughly 12% annually over the past three decades. A dollar invested in Ecolab stock in 1990 is worth approximately $40 today, outperforming the S&P 500 by a wide margin. The company has made over 150 acquisitions since its founding, nearly all of them tuck-ins that extend its service capabilities into adjacent categories — a pest control company here, a laundry chemical specialist there, a water monitoring technology startup somewhere else. Each acquisition is individually modest; collectively, they have transformed a single-product company into a diversified platform.
The investors who have done best with Ecolab are the ones who understood that the company's value creation is not event-driven. There is no iPhone launch, no platform shift, no viral moment. There is instead the daily accumulation of small advantages: a field rep who identifies a cross-selling opportunity, a price increase that sticks, a customer who adds water treatment to an existing cleaning contract, a new dispensing system that reduces chemical waste by 8%. Multiplied across three million locations and compounded over years, these incremental gains produce extraordinary results.
This is not the kind of story that generates excitement. It is the kind of story that generates wealth.
The company's capital allocation reflects this temperament. Ecolab spends approximately $600–700 million annually on capital expenditures, primarily on dispensing equipment deployed at customer sites (a form of capex that deepens switching costs — the customer can't use Ecolab's dispensers with a competitor's chemicals). R&D spending runs approximately $200 million per year, focused on next-generation chemistry and digital monitoring tools. Share repurchases and dividends consume most of the remaining free cash flow. Debt levels, elevated after the Nalco acquisition, have been methodically reduced.
There is something almost monastic about the operation. No flash. No reinvention. Just the patient, daily work of keeping the world clean and the water safe, priced at a premium, delivered with consistency, and compounded over time.
In 2024, as Christophe Beck stood before investors at the company's annual meeting in St. Paul — barely ten miles from the dairy plant basement where Merritt Osborn first watched a worker fail to clean a milk bottle — he described Ecolab's next decade in terms that Osborn himself might have used. "We help our customers do more with less," Beck said. "Less water. Less energy. Less waste. Less risk." On the screen behind him, a single number: 40 billion gallons of water saved for customers in the prior year. Forty billion gallons — enough to meet the annual drinking water needs of over 700 million people. The napkin in the water, still absorbing.
